Myocardial Inflammation and Dysfunction in COVID-19-Associated Myocardial Injury

Ludwig T Weckbach1,2,3,4, Adrian Curta5, Stephanie Bieber1,4

  • 1Medical Department I (L.T.W., S.B., A.K., J.B., C.S., S.K., M.O., S. Massberg, J.H., U.G.), Ludwig-Maximilians-University, Munich, Germany.

Insights

COVID-19 patients with myocardial injury show reduced heart strain and myocarditis patterns on MRI. Macrophage increase was noted, but not widespread lymphocytic myocarditis, with some recovery observed.

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Medical Imaging

Background:

  • Myocardial injury in COVID-19 is linked to poor outcomes, but its frequency and causes like myocarditis are uncertain.
  • Elevated troponin levels indicate myocardial injury, a significant concern in coronavirus disease 2019 (COVID-19) patients.

Purpose of the Study:

  • To prospectively assess myocardial injury in hospitalized COVID-19 patients.
  • To characterize cardiac changes using echocardiography, cardiac MRI, and endomyocardial biopsy.

Main Methods:

  • Prospective assessment of 18 COVID-19 patients with myocardial injury.
  • Utilized transthoracic echocardiography, cardiac MRI, and endomyocardial biopsy.
  • Analyzed left ventricular ejection fraction, global longitudinal strain, and myocardial tissue characteristics.

Main Results:

  • Reduced left ventricular global longitudinal strain (-11.2%) observed.
  • Cardiac MRI revealed nonischemic myocardial injury in 83.3% and myocarditis criteria in 38.9%.
  • Endomyocardial biopsies showed increased macrophages in all patients, with lymphocytic myocarditis in one; SARS-CoV-2 RNA was undetectable.

Conclusions:

  • COVID-19 myocardial injury presents with reduced left ventricular strain and myocarditis patterns on MRI.
  • Endomyocardial biopsies indicated macrophage activation rather than predominant lymphocytic myocarditis.
  • Functional cardiac improvements were noted during follow-up.
Abstract

Related Concept Videos

Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
162
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
72
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
103
Myocarditis IV: Nursing Management01:22

Myocarditis IV: Nursing Management

Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
106
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
152
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
135